HK2 and hepatocellular carcinoma: MiR-3662 and miR-125a act as suppressors for glucose metabolism by HK2 inhibition, and suppress cell proliferation, invasion, or apoptosis in hepatocellular carcinoma cells in vitro [24, 32].